tag heart-failure 
Rethinking Clinical Trials
JULY 13, 2023
The daily workflow consisted of a daily electronic health record (EHR) query that identified patients who had heart failure with reduced ejection fraction, who were admitted for any cause within sites in the healthcare system. Patients went through a screening by a study physician for eligibility.
Rethinking Clinical Trials
DECEMBER 6, 2022
Pragmatic Clinical Trials, Heart Failure, Diabetes. that focused on patients with heart failure and diabetes, two rapidly growing conditions that are highly morbid. The post Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
FEBRUARY 20, 2024
The MINT trial investigators looked at 30-day mortality and several outcomes including MI, heart failure, stroke, bleeding, infection, and clot. Finally, heart failure and other safety outcomes were comparable in the two transfusion groups. In general, I think as these things go, it was quite positive.
Rethinking Clinical Trials
AUGUST 22, 2022
Trial participants were adults ages 30-85, who tested positive for SARS-CoV-2 within 3 days, with fewer than 7 days of symptoms, no known prior infection with SARS-CoV-2, no severe kidney, liver, or heart failure. We also kept equal focus on follow-up. Learn more about COVID-OUT. pctGR, @Collaboratory1.
World of DTC Marketing
SEPTEMBER 9, 2021
of hospitals were fully compliant with the new price transparency rule, with most failures centered on not posting payer-negotiated prices. A study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke, and type 2 diabetes.
pharmaphorum
JANUARY 11, 2022
Last year, Biofourmis said its heart failure tool BiovitalsHF was the first DTx to be awarded breakthrough status by the FDA. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on. Breakthrough designations can speed up the development of new therapies, making them available to patients sooner.
Rethinking Clinical Trials
APRIL 27, 2023
The primary composite outcome was cardiovascular mortality or hospital admission with MI, stroke, or heart failure. The mean temperature for the standard group was 36.4 degrees C, and the mean temperature for cooler group was 35.8 There was no appreciable difference in the estimate for the cooler temperature group.
Expert insights. Personalized for you.
130 
Let's personalize your content